419 related articles for article (PubMed ID: 26721597)
21. Matrix modulation and heart failure: new concepts question old beliefs.
Deschamps AM; Spinale FG
Curr Opin Cardiol; 2005 May; 20(3):211-6. PubMed ID: 15861009
[TBL] [Abstract][Full Text] [Related]
22. Myocardial remodelling and matrix metalloproteinases in heart failure: turmoil within the interstitium.
Wilson EM; Spinale FG
Ann Med; 2001 Dec; 33(9):623-34. PubMed ID: 11817657
[TBL] [Abstract][Full Text] [Related]
23. Cardiac restricted overexpression of membrane type-1 matrix metalloproteinase causes adverse myocardial remodeling following myocardial infarction.
Spinale FG; Mukherjee R; Zavadzkas JA; Koval CN; Bouges S; Stroud RE; Dobrucki LW; Sinusas AJ
J Biol Chem; 2010 Sep; 285(39):30316-27. PubMed ID: 20643648
[TBL] [Abstract][Full Text] [Related]
24. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction.
Hayashidani S; Tsutsui H; Shiomi T; Ikeuchi M; Matsusaka H; Suematsu N; Wen J; Egashira K; Takeshita A
Circulation; 2003 Oct; 108(17):2134-40. PubMed ID: 14517168
[TBL] [Abstract][Full Text] [Related]
25. Extracellular degradative pathways in myocardial remodeling and progression to heart failure.
Spinale FG; Gunasinghe H; Sprunger PD; Baskin JM; Bradham WC
J Card Fail; 2002 Dec; 8(6 Suppl):S332-8. PubMed ID: 12555141
[TBL] [Abstract][Full Text] [Related]
26. Early matrix metalloproteinase-12 inhibition worsens post-myocardial infarction cardiac dysfunction by delaying inflammation resolution.
Iyer RP; Patterson NL; Zouein FA; Ma Y; Dive V; de Castro Brás LE; Lindsey ML
Int J Cardiol; 2015 Apr; 185():198-208. PubMed ID: 25797678
[TBL] [Abstract][Full Text] [Related]
27. Using proteomics to uncover extracellular matrix interactions during cardiac remodeling.
Patterson NL; Iyer RP; de Castro Brás LE; Li Y; Andrews TG; Aune GJ; Lange RA; Lindsey ML
Proteomics Clin Appl; 2013 Aug; 7(7-8):516-27. PubMed ID: 23532927
[TBL] [Abstract][Full Text] [Related]
28. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling.
Li YY; McTiernan CF; Feldman AM
Cardiovasc Res; 2000 May; 46(2):214-24. PubMed ID: 10773225
[TBL] [Abstract][Full Text] [Related]
29. Extracellular matrix remodeling attenuated after experimental postinfarct left ventricular aneurysm repair.
Hsu CP; Huang CY; Wang JS; Sun PC; Shih CC
Ann Thorac Surg; 2008 Oct; 86(4):1243-9. PubMed ID: 18805169
[TBL] [Abstract][Full Text] [Related]
30. Acute left ventricular remodeling following myocardial infarction: coupling of regional healing with remote extracellular matrix expansion.
Chan W; Duffy SJ; White DA; Gao XM; Du XJ; Ellims AH; Dart AM; Taylor AJ
JACC Cardiovasc Imaging; 2012 Sep; 5(9):884-93. PubMed ID: 22974800
[TBL] [Abstract][Full Text] [Related]
31. Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling.
Yarbrough WM; Mukherjee R; Escobar GP; Mingoia JT; Sample JA; Hendrick JW; Dowdy KB; McLean JE; Lowry AS; O'Neill TP; Spinale FG
Circulation; 2003 Oct; 108(14):1753-9. PubMed ID: 12975256
[TBL] [Abstract][Full Text] [Related]
32. Cardiac fibroblast activation during myocardial infarction wound healing: Fibroblast polarization after MI.
Daseke MJ; Tenkorang MAA; Chalise U; Konfrst SR; Lindsey ML
Matrix Biol; 2020 Sep; 91-92():109-116. PubMed ID: 32446909
[TBL] [Abstract][Full Text] [Related]
33. The compendium of matrix metalloproteinase expression in the left ventricle of mice following myocardial infarction.
Kaminski AR; Moore ET; Daseke MJ; Valerio FM; Flynn ER; Lindsey ML
Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H706-H714. PubMed ID: 32083973
[TBL] [Abstract][Full Text] [Related]
34. The plasminogen-MMP system is more activated in the scar than in viable myocardium 3 months post-MI in the rat.
Gaertner R; Jacob MP; Prunier F; Angles-Cano E; Mercadier JJ; Michel JB
J Mol Cell Cardiol; 2005 Jan; 38(1):193-204. PubMed ID: 15623436
[TBL] [Abstract][Full Text] [Related]
35. Effect of ramipril and furosemide treatment on interstitial remodeling in post-infarction heart failure rat hearts.
Seeland U; Kouchi I; Zolk O; Itter G; Linz W; Böhm M
J Mol Cell Cardiol; 2002 Feb; 34(2):151-63. PubMed ID: 11851355
[TBL] [Abstract][Full Text] [Related]
36. Reduced scar maturation and contractility lead to exaggerated left ventricular dilation after myocardial infarction in mice lacking AMPKα1.
Noppe G; Dufeys C; Buchlin P; Marquet N; Castanares-Zapatero D; Balteau M; Hermida N; Bouzin C; Esfahani H; Viollet B; Bertrand L; Balligand JL; Vanoverschelde JL; Beauloye C; Horman S
J Mol Cell Cardiol; 2014 Sep; 74():32-43. PubMed ID: 24805196
[TBL] [Abstract][Full Text] [Related]
37. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].
Yang YJ; Zhang X; Zhu WL; Huang Y
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1693-6. PubMed ID: 16854324
[TBL] [Abstract][Full Text] [Related]
38. Fibroblasts in myocardial infarction: a role in inflammation and repair.
Shinde AV; Frangogiannis NG
J Mol Cell Cardiol; 2014 May; 70():74-82. PubMed ID: 24321195
[TBL] [Abstract][Full Text] [Related]
39. Regulation of Myocardial Extracellular Matrix Dynamic Changes in Myocardial Infarction and Postinfarct Remodeling.
Ushakov A; Ivanchenko V; Gagarina A
Curr Cardiol Rev; 2020; 16(1):11-24. PubMed ID: 31072294
[TBL] [Abstract][Full Text] [Related]
40. Myocardial infarction remodeling that progresses to heart failure: a signaling misunderstanding.
Mouton AJ; Rivera OJ; Lindsey ML
Am J Physiol Heart Circ Physiol; 2018 Jul; 315(1):H71-H79. PubMed ID: 29600895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
